Influence of obesity assessments on cardiometabolic risks in African and European American women
Related Experiment Video
Updated: Apr 20, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Insights
Cardiometabolic (CME) risks differ between African American women (AAW) and European American women (EAW) when evaluated by obesity. Systolic blood pressure and triglycerides were key risks for AAW, while SBP and glucose were significant for EAW.
Area of Science:
- Cardiology
- Public Health
- Obesity Research
Background:
- African American women (AAW) exhibit higher risks for cardiometabolic (CME) diseases and cardiovascular diseases (CVD) compared to European American women (EAW).
- The specific impact of obesity on CME risk clustering and CVD disparities in AAW remains incompletely understood.
Purpose of the Study:
- To develop a comprehensive CME index.
- To investigate the relationship between obesity and CME risk index patterns stratified by race.
Main Methods:
- A comparative research design involving 213 women (132 AAW, 81 EAW) from the Louisiana Delta.
- Assessment of CME risk clustering using Body Mass Index (BMI), dual-energy X-ray absorptiometry % body fat, and waist circumference.
- Measurement of fasting glucose, triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), systolic blood pressure (SBP), and diastolic blood pressure (DBP) as key CME risks.
Main Results:
- For AAW, SBP and TG were identified as significant CVD risks or near risks within obesity classifications.
- For EAW, SBP and glucose trends indicated higher CME risk.
- Stepwise regression revealed HDL-C and SBP/DBP as primary indicators of obesity's impact on CME risks in AAW, whereas SBP/DBP and glucose were key for EAW.
Conclusions:
- Obesity-based CME risk profiles demonstrate distinct patterns between AAW and EAW.
- Understanding these race-specific differences is crucial for targeted public health interventions and clinical management of cardiometabolic health.
Objectives:
African American women (AAW) have increased odds of developing cardiometabolic (CME) risks and cardiovascular diseases (CVD) compared with European American women (EAW). The influence of obesity on other CME risks and the CVD disparity is unclear. The purpose of our study was to develop a CME index and evaluate the obesity and CME risk index relationships based on race.
Design:
A comparative research design was employed in our study as 213 women (132 AAW; 81 EAW) from the Louisiana Delta were evaluated for CME risk clustering patterns by race, based on BMI, dual energy X-ray absorptiometry % body fat and waist conference. Fasting glucose, triglyceride (TC), high density lipoprotein cholesterol (HDL-C), systolic (SBP) and diastolic blood pressure (DBP) were the measured CME risks.
Findings:
In summary, when the CME indexes were evaluated by obesity classification categories the ones that were CVD risk or near risk for the AAW were SBP and TG. The trend of CME index risk for the EAW was SBP and glucose. The stepwise regression equations indicate that HDL-C and SBP/DBP were the best indicators of the effects of obesity on CME risks in AAW and that SBP/DBP and glucose were the best indicators of CME risks in EAW.
Conclusions:
Our results indicate that CME risks as evaluated based on obesity categories are different for AAW than for EAW.
Related Concept Videos
Obesity
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Coronary Artery Disease I: Introduction
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...

